This week saw the revelationĀ that a so called peer reviewed study, claiming a correlation between vaccinations and the cause of autism was invalid, despite its being published in the respected medical journal The Lancet. The two critical qualifications for acceptance of findings of major scientific studies has been peer review and publication acceptance...
Continue reading…
Category: Pharmaceutical
Massachusetts Doctor Gets Over $10 million for Being Elan Whistleblower
Newton Massachusetts Psychiatrist Dr. Lee R. Chartock is about to receive over $10 million for his role in being the whistleblower in the case against Irish pharma giant Elan Corporation and its subsidiary Elan Pharmaceuticals Inc.. Elan Corporation PLC is a publicly traded neuroscience based biotech company. (ELN). The company has agreed to pay...
Continue reading…
RECALLED DEOUY HIP IMPLANT NEVER HAD FDA APPROVAL
According to an article in the New York Times, the recalled DePuy hip implant was never approaved by the FDA because it fell into an FDA loophole. Beginning in 2005 DePuy, a division of Johnson & Johnson, was allowed to sell and market its ASR XL Acetabular System in the U.S. without FDA approval....
Continue reading…
Abbott Subsidiary Pays $41 M to Settle Whistleblower Suit for Doc Kickbacks
Kos Pharmaceuticals a subsidiary of Abbott, will pay over $41 million to resolve False Claims Actions related to allegations that it paid doctors money, free travel, grants and other valuable goods to get them to prescribe Niaspan and Advicor. The whistleblower will receive $6.4 million for informing Uncle Sam
FIRST LEVAQUIN TENDON RUPTURE SUIT RESULTS IN $1.8 MILLION VERDICT
A jury has awarded $1.8 million in the first Levaquin lawsuit against Johnson & Johnson for recklessly failing to warn consumers and doctors about the risk of tendon ruptures from Levaquin. The case involved an 82-yearold man who suffered an achilles tendon rupture after taking the drug and his case was the first to...
Continue reading…
SENIORCARE AGREES TO PAY $1.3 FOR DRUG RECYCLING
Long term care Pharmacy Remedi Seniorcare Inc has agreed to pay $1.3 million to resolve a whistleblower claim that it unlawfully recycled, repackages, redistributed and re-billed thousands of drugs to Medicare and Medicaid beneficiaries. The whistleblower estimated that the percentage of recycled medicine to resulted in 80% of what was entrusted to the company...
Two physician researchers from Harvard Medical School have raised their concern in the New England Journal of Medicine
Two physician researchers from Harvard Medical School and Brigham & Women's Hospital, Jeremy Greene and Aaaron Kesselheim have raised their concern in the New England Journal of Medicine, about the possible manipulation of social media as a marketing tool by drug makers. They suggest that secret conflicts of interest are a major concern--for example...
Continue reading…
CONCERN THAT DRUG COMPANIES WILL MANIPULATE SOCIAL MEDIA
Two physician researchers from the Harvard Medical School and The Brigham & Women's Hospital have said that they are concerned that social media may become a vehicle of drug company marketing and rabid manipulation. The comments published in the New England Journal of Medicine suggested that the FDA oversee the social media landscape to...
Continue reading…
Glaxo Whistleblower Gets $96 million Reward
Cheryl Eckard was paid $96 million, the largest amount ever received by a whistleblower. She reported violations in the Glaxo Puerto Rico facility. Pills were being made with incorrect doses and some of the drugs were contaminated. The whistleblower tried to convince the plant executives to fix the problems before she reported it.
AARP JOINS MAJOR WHISTLEBLOWER SUIT ON STENTS
AARP has signed on as co-counsel in a major whistleblower lawsuit against Abbott labs, Johnson & Johnson and Boston Scientific for off label marketing of metal billiary stends. In this suit, the whistleblower, a former sals rep for Guidant, says that the stents were incorrectly placed in older patients to treat vacular disease but...
Continue reading…